Bladder Cancer - Results from #50

REVIEW UroToday

Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary Bladder. October 7, 2024

The genomic and transcriptomic landscape of metastastic urothelial cancer. October 7, 2024

Quantification of micropapillary component on transurethral resection is associated with likelihood of occult lymph node metastasis at radical cystectomy. October 7, 2024

Does the Extent of Transurethral Resection after Radiation Therapy Impact Survival Outcomes in Muscle-Invasive Bladder Cancer - Expert Commentary October 4, 2024

Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase III Multicentre Randomized Controlled Trial: Acute and late toxicity in BART RCT. October 4, 2024

Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis. October 4, 2024

Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial. October 4, 2024

Gut Microbiota Influence Bladder Tumour Development October 3, 2024

Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer October 3, 2024

The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement. October 3, 2024

Bacillus Calmette-Guerin (BCG) Vaccine Impact on Dementia Risk in Bladder Cancer Patients: A Systematic Review and Meta-Analysis. October 3, 2024

Characterizing Psychological Resources and Resilience in Patients With Bladder Cancer: Associations With Frailty and Quality of Life. October 2, 2024

Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy. October 2, 2024

Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients. October 1, 2024

Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC): Considerations from the European Association of Urology NMIBC Guideline Panel. October 1, 2024

Prognostic Nomogram, Demographics and Comparative Analysis of Urinary Bladder Small Cell and Large Cell Neuroendocrine Carcinoma. October 1, 2024

Adjuvant radiation therapy for locally advanced bladder cancer: A safe and promising emerging treatment option September 30, 2024

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs September 30, 2024

Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value. September 30, 2024

Risk of Progression of High-grade Primary T1 Non-muscle-invasive Bladder cancer in a Contemporary Cohort. September 30, 2024

Page 3 of 517